UR-5908

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameUR-5908
Drug Alias NamePDE 4 inhibitor (Summit Pharmaceuticals/UBE Industries)COPD therapy (UBE Industries)UR-5908
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUbe Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUbe CorpSummit Pharmaceuticals International
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A